Lina Degenfeld-Schonburg

Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity

A. Reiter, H. Simon, P. Valent, 2021, Seminars in Immunopathology.

Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD+ Acute Myeloid Leukemia

R. Moriggl, P. Valent, E. Hadzijusufovic, 2021, Cancers.

Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations.

T. Lion, G. Stefanzl, P. Valent, 2021, American journal of cancer research.

Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph+ Chronic Myeloid Leukemia

G. Stefanzl, P. Valent, W. Sperr, 2022, Cells.

Drug-Induced Mast Cell Eradication: A Novel Approach to Treat Mast Cell Activation Disorders?

M. Triggiani, K. Sotlar, P. Valent, 2022, The Journal of allergy and clinical immunology.

Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.

G. Stefanzl, P. Jaksch, P. Valent, 2023, American journal of cancer research.

Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils

G. Stefanzl, P. Jaksch, W. Sperr, 2024, Cells.